Cisplatin in renal transplant recipients: not an absolute contraindication
LaVoy, Rachel E.
Hu, Peter T.
Metadata[+] Show full item record
The chemotherapeutic agent cisplatin is usually contraindicated in renal transplant recipients due to its well-known side effect of nephrotoxicity, but is an important (and sometimes irreplaceable) drug in the management of cancer. We report a case of cisplatin usage concurrently with radiation (CRT) in unresectable head and neck cancer, along with a review of the literature.
2012 Health Sciences Research Day